SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-013799
Filing Date
2020-02-10
Accepted
2020-02-10 17:28:04
Documents
1
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv537831_sc13ga.htm SC 13G/A 60855
  Complete submission text file 0001104659-20-013799.txt   62410
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Subject) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89971 | Film No.: 20593092
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT X1 07901
Business Address 86 MORRIS AVENUE SUMMIT X1 07901 908-673-9000
Celgene Alpine Investment Co., LLC (Filed by) CIK: 0001581774 (see all company filings)

IRS No.: 454054818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A